The arithmetic of Liberation Day at one year is this: $166 billion collected from American importers under tariffs the Supreme Court ruled unconstitutional on February 20. A refund portal that has attracted 26,664 registrations accounting for $120 billion in claims, but has not yet issued a single payment [1]. A replacement 10% global tariff under Section 122 of the Trade Act of 1974 that expires on July 23, covering only a fraction of what IEEPA once reached [2]. And, on the anniversary itself, new executive orders imposing up to 100% tariffs on patented pharmaceutical imports [3].

As this paper documented yesterday, the original Liberation Day tariffs shed over 100,000 manufacturing jobs and failed to shrink the trade deficit. Today the story advances: the administration is not retreating from tariffs. It is rebuilding them on different legal ground, faster than the courts can strike them down.

The Cato Institute's anniversary assessment found that as many as 64% of U.S. imports are now exempt from Section 122 tariffs, suggesting the administration itself has acknowledged the policy cannot operate at IEEPA's scope [4]. The American Action Forum estimated Section 122 tariffs will cost consumers and businesses roughly $25 billion during their 150-day window [5]. The effective tariff rate on U.S. imports currently sits at approximately 10.3%, a level not seen since 1947 according to a Mas Economics analysis of trade data [6].

The pharmaceutical tariffs announced Thursday are the most aggressive sectoral move since IEEPA fell. Trump signed an executive order authorizing tariffs of up to 100% on certain branded drugs from companies that fail to negotiate manufacturing concessions with the administration [3]. AP reported that many companies are initially exempt, with months to negotiate before the tariffs take effect. The structure is designed to force pharmaceutical investment into domestic production -- the same rationale that animated the original Liberation Day tariffs, applied to a sector where supply chain disruption carries life-or-death consequences.

Meanwhile, U.S. Customs and Border Protection confirmed this week that the IEEPA refund portal is "on track" to begin accepting claims by the April 20 deadline, though payments may take up to 45 days after submission [7]. The Wharton Budget Model projects total refunds could reach $175 billion [8]. Small businesses, which account for the vast majority of importers, have been largely shut out of the process: the first 26,664 registrants represent only 8% of eligible claimants but account for $120 billion in claims, meaning the largest importers registered first and the smallest are still waiting [1].

The Section 122 tariff is itself being challenged. Twenty-four states filed suit in the U.S. Court of International Trade on March 5, arguing the provision was never intended to serve as a general tariff authority [9]. The tariff expires in July. Section 301 investigations covering 76 countries are running toward potential permanent tariffs. The administration is building a legal patchwork where a single constitutional framework once stood.

One year after Liberation Day, the president has lost the legal authority he claimed, owes more than $166 billion to the businesses he taxed, and responded by announcing even larger tariffs on a new sector. The policy did not work. The refunds have not arrived. The tariffs keep coming.